Peter Wallenhorst1, Joshua Rutland1, John Gurley1, Maya Guglin1,21University of Kentucky, Lexington, Kentucky, USA
2Electronic correspondence: email@example.com
|The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had||failed multiple antibiotic regimens and was deemed a poor surgical candidate.
The Journal of Heart Valve Disease 2018;27:120-123
|Use of AngioVac for Removal of Tricuspid Valve Vegetation|
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.